Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balstilimab in Advanced Solid Tumors and Cervical Cancer
NCT03104699Phase 2Completed
- Sponsor
- Agenus Inc.
- Start
- Apr 2017
- Primary completion
- Jun 2022
- Modality
- Monoclonal Antibodies, Vaccines & Immunotherapeutics
- Countries
- 9
01
Overview
A Phase 2 trial of balstilimab in solid tumor, Cervical Cancer (CC), sponsored by Agenus Inc.. Started Apr 2017; status: completed.
02
Drugs
balstilimab
03
Conditions
solid tumorCervical Cancer (CC)
Beyond the preview
Go deeper on NCT03104699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104699.